SCHEMBL19205464

SCHEMBL19205464

CC(C)=CCC[C@H](C)CCN1C(=O)c2ccc3c4c(Br)cc5c6c(cc(Br)c(c7ccc(c2c37)C1=O)c64)C(=O)N(CC[C@@H](C)CCC=C(C)C)C5=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 8/20 0.40
STAT3 P40763 1/20 0.36
HIF1A Q16665 1/20 0.36
NFE2L2 Q16236 2/20 0.35
KEAP1 Q14145 1/20 0.35
TLR9 Q9NR96 1/20 0.35
CYP1B1 Q16678 1/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
NPC1 O15118 2/20 0.33
LMNA P02545 2/20 0.33
PABPC1 P11940 2/20 0.33
KMT2A Q03164 2/20 0.33
RGS12 O14924 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19205475 0.97 TERT (0.38) TERTSTAT3HIF1ANFE2L2KEAP1
SCHEMBL19205403 0.88 TERT (0.40) TERTSTAT3HIF1ANFE2L2KEAP1
SCHEMBL1264413 0.85 TERT (0.38) TERTSTAT3HIF1ANFE2L2KEAP1
SCHEMBL19205460 0.84 NFE2L2 (0.38) TERTSTAT3HIF1ANFE2L2KEAP1
SCHEMBL17514375 0.83 TP53 (0.37) NFE2L2CYP1B1KDM4EALOX15MAPT
SCHEMBL17514378 0.82 POLB (0.34) STAT3NFE2L2ALDH1A1KDM4EPOLB
SCHEMBL1263847 0.82 TERT (0.36) TERTSTAT3HIF1ANFE2L2KEAP1
SCHEMBL17514394 0.80 TP53 (0.38) NFE2L2CYP1B1KDM4EALOX15MAPT
SCHEMBL17514385 0.79 POLB (0.34) STAT3NFE2L2ALDH1A1KDM4EPOLB
SCHEMBL12672596 0.77 TERT (0.33) TERTNFE2L2KEAP1TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3183250-B1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL CLAP CO LTD (KR) 2023-10-04 EP disclosed
EP-3183757-B1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM CLAP CO LTD (KR) 2022-05-04 EP disclosed
US-10454037-B2 Organic semiconductor composition comprising a liquid medium BASF SE (DE) 2019-10-22 US disclosed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 US disclosed
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM BASF SE (DE) 2017-08-31 US disclosed
US-20170237005-A1 PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL BASF SE (DE) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM CRY1, NEFM, OR10J3 TERT 1542/4885STAT3 225/4885HIF1A 4242/4885
US-10454037-B2 Organic semiconductor composition comprising a liquid medium CRY1, NEFM, OR10J3 TERT 1542/4885STAT3 225/4885HIF1A 4242/4885
US-10224485-B2 Process for preparing a crystalline organic semiconductor material STOM, SPOP, TTR TERT 2496/4885STAT3 4044/4885HIF1A 4266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.